Jiangsu Apon Medical Technology Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Since its establishment in 2001, Jiangsu Aipeng Medical Technology Co., Ltd. (hereinafter referred to as "Aipeng Medical", securities code 300753) has actively engaged in the comfort medical and health industry in China. It has always been based on clinical needs, evidence-based medicine as the research and development basis, and craftsmanship and quality as the business philosophy. It has been deeply rooted in the two sub fields of pain management and nasal care for many years, Determined to become a "leader in comfort based medical intelligent devices" in the medical segmented industry. At present, it has Aipu Scientific Instruments (Jiangsu) Co., Ltd., Shanghai Nuoqing Biotechnology Co., Ltd., Jiangsu Aizhong Yihui Medical Technology Co., Ltd., Jiangsu Pengzhong Yihui Medical Technology Co., Ltd., Jiangsu Aipeng Medical Technology Development Co., Ltd., Sichuan Jinjiazheng Medical Equipment Co., Ltd., Shanghai Xiaopeng Technology Co., Ltd., and Shenzhen Baishikang Medical Equipment Co., Ltd. |
| Headquarter | Nantong |
| Establish Date | 10/30/2001 |
| Listed Code | 300753.SZ |
| Listed Date | 12/13/2018 |
| Chairman | Wang Ningyu. |
| CEO | Zhang Zhizhi. |
| Website | www.apon.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
